Massive Rhabdomyolysis following Cardiopulmonary Bypass

Ledingham JG. Acute renal failure. In: Weatherall DJ , Ledingham JG , Warrell DA , eds Oxford Textbook of Medicine, 2nd ed. Oxford University Press, Oxford 1987; 18.131.

European Malignant Hyperpyrexia Group. A Protocol for the investigation of malignant hyperpyrexia susceptibility. Br J Anaesth 1984; 56:1267–1269.

Wappler F , Roewer N , Lenzen C et al. High-purity ryanodine and 9,21-dehydroryanodine for in vitro diagnosis of malignant hyperthermia in man. Br J Anaesth 1994; 72:240–242.

Ording H. Diagnosis of susceptibility to malignant hyperthermia in man. Br J Anaesth 1988; 60:287–302.

Halsall PJ , Cain PA , Ellis FR. Retrospective analysis of anaesthesia received by patients before susceptibility to malignant hyperpyrexia was recognised. Br J Anaesth 1979; 51:949–954.

Comunale ME , DiNardo JA , Schwartz MJ. Pharmacokinetics of dantrolene in an adult patient undergoing cardiopulmonary bypass. J Cardiothor Vasc Anesth 1991; 5:153–155.

Byrick RJ , Rose DK , Ranganathan N. Management of a malignant hyperthermia patient during cardiopulmonary bypass. Can Anaesth Soc J 1982; 29:50–54.

Hachenberg T , Brussel T , Lawin P , Konertz W , Scheld HH. Heart transplantation in a patient with central core disease. J Cardiothor Vasc Anesth 1992; 6:386–387.

MacGillivray RG , Jann H , Vanker E , Gemmell L , Mahomedy AE. Development of malignant hyperthermia obscured by cardiopulmonary bypass. Can Anaesth Soc J 1986; 33:509–514.

Quinn RD , Pae WE , McGary SA , Wickey GS. Development of malignant hyperthermia during mitral valve replacement. Ann Thor Surg 1992; 53:1114–1116.

Murphy AL , Conlay L , Ryan JF , Roberts JT. Malignant hyperthermia during a prolonged anesthetic for reattachment of a limb. Anesthesiology 1984; 60:149–150.

Allen GC , Cattran CB. Rewarming following hypothermic cardiopulmonary bypass in the malignant hyperthermia-susceptible patient: Implications for diagnosis and perioperative management. Can J Anaesth 1989; 36:81–85.

Gronert GA , Milde JH. Variations in onset of porcine malignant hyperthermia. Anesth Analg 1981; 60:499–503.

Nelson TE. Porcine malignant hyperthermia: critical temperatures for in vivo and in vitro responses. Anesthesiology 1990; 73:449–454.

Miller ED , Sanders DB , Rowlingson JC , Berry FA , Sussman MD , Epstein RM. Anesthesia-induced rhabdomyolysis in a patient with Duchenne's muscular dystrophy. Anesthesiology 1978; 48:146–148.

Farrell PT. Anaesthesia-induced rhabdomyolysis causing cardiac arrest: case report and review of anaesthesia and the dystrophinopathies. Anaesth Intens Care 1994; 22:597–601.

Sullivan M , Thompson WK , Hill GD. Succinylcholine-induced cardiac arrest in children with undiagnosed myopathy. Can J Anaesth 1994; 41:497–501.

Lehmann-Horn F , Iaizzo PA. Are myotonias and periodic paralyses associated with susceptibility to malignant hyperthermia? Br J Anaesth 1990; 65:692–697.

Russell SH , Hirsch NP. Anaesthesia and myotonia. Br J Anaesth 1994; 72:210–216.

Chalkialdis GA , Branch KG. Cardiac arrest after isoflurane anaesthesia in a patient with Duchenne's muscular dystrophy. Anaesthesia 1990; 45:22–25.

Rubiano R , Chang J-L , Carroll J , Sonbolian N , Larson CE. Acute rhabdomyolysis following halothane anaesthesia without succinylcholine. Anesthesiology 1987; 67:856–857.